CorVel Corporation (CRVL) Company Overview

What does CorVel Corporation do?

CorVel Corporation is a U.S. healthcare-management and insurance-services company that helps employers, insurers, third-party administrators, and government entities control the medical and administrative cost of workers’ compensation, automobile, liability, and group-health claims. Its common stock trades on the Nasdaq Global Select Market under CRVL. The business is best understood as a technology-enabled managed-care operator rather than an insurer: CorVel generally manages claims, medical networks, bills, treatment pathways, and recovery processes for customers that retain the underlying insurance risk.

How should researchers classify the business?

CorVel reports one operating segment, managed care, but discloses two service lines: patient management and network solutions. Its fiscal 2026 Form 10-K describes an integrated model combining claims professionals, clinical expertise, provider access, data, and proprietary software. The offering can be purchased as a full claims-management program, as standalone services, or as targeted additions to an existing program.

How does CorVel make money?

CorVel earns fees for processing, managing, reviewing, and coordinating claims and healthcare services. Contracts can be priced per claim, per transaction, per covered employee, through network-access arrangements, or through combinations tailored to customer programs. The economic value proposition is straightforward: customers pay CorVel to reduce claim duration, avoid unnecessary treatment, identify billing errors, negotiate provider charges, and return injured workers to health and work more efficiently.

Which service line drives growth?

Patient management remains the larger revenue base, but network solutions has become the faster growth engine. In FY2026, network solutions revenue increased 15%, while patient management increased 3%. That mix shift matters because bill review, CERIS payment-integrity work, pharmacy, and directed-care coordination can scale through software, specialized rules, and transaction volume. The company’s official workers’ compensation services page shows how these capabilities are bundled around a claim rather than sold as isolated tools.

Why can the model produce recurring demand?

Claims do not recur like a fixed software subscription, yet relationships can be durable because customers repeatedly generate new claims, integrate CorVel into workflows, and depend on regulatory reporting, provider access, historical data, and consistent service levels. No customer represented 10% or more of FY2026 revenue, reducing single-client revenue dependence. However, two customers each represented at least 10% of accounts receivable at March 31, 2026, so collection concentration still deserves attention.

What do the latest quarter and FY2026 results show?

The quarter ended March 31, 2026 closed a year of moderate revenue growth and faster profit growth. CorVel’s fourth-quarter and fiscal 2026 earnings release reported quarterly revenue of $248.5M, up 7.4% from $231.5M a year earlier. Quarterly net income increased 17.5% to $31.0M, while diluted EPS rose to $0.61 from $0.51.

Where did operating leverage appear?

Quarterly gross profit reached $63.0M and income before income taxes was $39.7M. For the full year, revenue rose 7.0% to $958.5M, gross profit increased to $232.9M, income before income taxes reached $143.1M, and net income advanced 15.9% to $110.3M. The FY2026 pre-tax margin was 14.9%, compared with 13.5% in FY2025. This indicates that service mix, pricing, automation, and expense discipline converted a mid-single-digit top-line gain into faster earnings growth.

How has the three-year trend changed?

Which turning points shaped CorVel’s current strategy?

CorVel’s history is less about headline acquisitions than about steadily building a national service platform, proprietary workflow technology, and disciplined per-share economics. The relevant milestones are those that explain why a claims-services company now resembles a healthcare data and payment-integrity platform.

1. 1987
   CorVel was incorporated in Delaware. The early foundation in managed care established the company’s focus on reducing claim cost rather than underwriting insurance risk.
2. 1991
   The company began trading on Nasdaq. Public-market access supported expansion while preserving an independently operated model.
3. 1996
   CorVel began its long-running share-repurchase program. Buybacks subsequently became the dominant mechanism for returning capital and improving per-share results.
4. 2024
   A three-for-one forward stock split increased the share count and reduced the per-share trading price without changing economic ownership.
5. June 2025
   CorVel acquired technology assets and key talent from a privately held firm to strengthen CERIS, reinforcing payment integrity as a strategic growth area.
6. FY2026
   Revenue approached $1.0B and network solutions reached 37.7% of the mix, confirming that bill review and directed-care services were gaining strategic weight.
7. July 1, 2026
   Sarah A. Scott became president and CEO, while Michael G. Combs moved to executive chair. The transition combined new operating leadership with continuity at the board level.

Why does the leadership transition matter?

The leadership-transition filing states that Scott had more than 26 years with CorVel and joined in 1999. That reduces the risk of a sudden strategic reset. Her incentives also emphasize the same operating agenda visible in the results: revenue, earnings per share, pre-tax income, CERIS growth and margin, artificial-intelligence deployment, customer diversification, and broader margin improvement.

What gives CorVel a competitive advantage?

CorVel’s advantage is not one patent or one network. It is the integration of claims operations, clinical expertise, payment integrity, provider access, and proprietary technology in a single workflow. A customer that uses CorVel for intake, triage, bill review, utilization management, pharmacy, case management, and reporting can avoid coordinating multiple vendors and can compare decisions across a common data environment.

How do data and software reinforce the model?

The company says its artificial-intelligence engine contains more than 100 million rules and uses machine learning and natural-language processing. Its technology platform supports CareMC, CorVel Connected, predictive analytics, automation, and digital claim workflows. Scale matters because every reviewed bill, treatment pattern, provider interaction, and claim outcome can expand the data used to flag anomalies or direct care.

What makes the provider network valuable?

The PPO network exceeded 1.2 million providers at March 31, 2026. Breadth creates national coverage, but the more important benefit is the ability to connect negotiated access with bill review and directed care. Through CareIQ, CorVel coordinates imaging, physical therapy, durable medical equipment, transportation, translation, and other services. The network is therefore both a discount mechanism and a routing system that can influence claim cost and recovery time.

Who competes with CorVel, and how is the market structured?

CorVel’s filings describe a fragmented competitive field rather than a single head-to-head rival. The company competes with third-party administrators, managed-care organizations, large insurance carriers, national healthcare-services vendors, preferred-provider organizations, smaller regional specialists, and customers’ own internal claims teams. Many competitors have more financial resources, larger sales organizations, or bundled insurance relationships.

What determines buyer power and rivalry?

Large customers can negotiate price and service levels, and contracts may be renewed, rebid, reduced, or brought in-house. That gives buyers meaningful power. CorVel counters with measurable savings, regulatory expertise, workflow integration, and the cost of migrating claim data and operating processes. Rivalry is strongest where a service is commoditized, such as basic network access; it is weaker where multiple modules, historical data, and clinical operations are embedded together.

How financially strong is CorVel?

CorVel ended FY2026 with $233.1M in cash and no borrowings, according to the annual earnings release. Current assets were $462.3M, current liabilities were $228.1M, and calculated working capital was approximately $234.2M. The company also held $101.3M of accounts receivable and $115.7M of customer deposits. This balance-sheet profile provides capacity to invest in software, absorb working-capital variability, repurchase shares, and pursue selective technology assets.

How much reinvestment does the model require?

The company is asset-light relative to an insurer or hospital system, but not capital-free. FY2026 purchases of property and equipment rose to $45.4M from $35.8M in FY2025, largely because of greater software development. Net property and equipment totaled $117.9M, including $49.6M of net internally developed software. This makes software capitalization, amortization, and product competitiveness important quality-of-earnings considerations.

How does capital allocation affect per-share value?

CorVel repurchased 782,744 shares for $56.2M in FY2026. Since the program began in 1996, it had bought 115.3M split-adjusted shares for approximately $887.7M through March 31, 2026. Repurchases can enhance EPS when made below intrinsic value, but they also compete with software investment and reduce liquidity. The key discipline question is whether buybacks continue after accounting for the reinvestment needed to keep CareMC, CERIS, and automation capabilities competitive.

Who owns CorVel stock, and why does governance matter?

CorVel has one class of common stock with one vote per share, but ownership is still concentrated. The 2026 proxy statement reported 51.0M shares outstanding at the record date and approximately 610 record holders. Jeffrey J. Michael beneficially owned 19.4M shares, or 37.99%; that amount included 18.7M shares held by Corstar Holdings. Directors and current executive officers as a group beneficially owned 39.72%.

What does concentrated ownership change?

Concentration can promote a long-term orientation and reinforce discipline around margins and buybacks, but it also means one shareholder can exert significant influence despite the absence of a dual-class structure. Investors should distinguish economic ownership from board oversight: five of six directors were independent, the board was declassified with annual elections, and the standing committees were composed of independent directors.

What opportunities and risks could change the story?

The central opportunity is to process more of each customer’s claim through CorVel’s platform. Enhanced bill review, CERIS prepayment and post-payment review, pharmacy, directed care, and artificial-intelligence tools can expand revenue per relationship while improving customer savings. Medical inflation can also support demand for cost containment, although it may raise CorVel’s own benefit and service-delivery expenses.

Which risks are most material?

The 10-K highlights lower national claim counts, fewer injured workers, contract renewal risk, intense competition, wage and benefit inflation, medical inflation, software obsolescence, cybersecurity incidents, litigation, and changing workers’ compensation and healthcare regulation. Because CorVel handles sensitive health and claim information, a security event could create remediation costs, operational interruption, contractual claims, and reputational damage at the same time.

Which operating KPIs deserve the closest attention?

CorVel does not publish subscription metrics such as ARR or churn, so researchers should use the disclosures that best reveal operating momentum: service-line revenue, gross margin, pre-tax margin, cash conversion, software investment, customer concentration, and share count. The company’s investor relations page is the practical starting point for new filings and results.

What matters most in a CorVel DCF and research takeaway?

A CorVel discounted-cash-flow model should not begin with insurance premiums or loss ratios because CorVel is not primarily underwriting risk. The model should begin with service revenue by line, especially the growth and mix contribution of network solutions. It should then translate that revenue into gross profit, operating expense, taxes, working-capital needs, capitalized software spending, and repurchases.

Which assumptions create the most sensitivity?

The most sensitive inputs are long-term network-solutions growth, the sustainable pre-tax margin, the level of software reinvestment, customer retention, and the terminal growth rate. A modest change in margin can materially alter free cash flow because CorVel already operates with nearly $1.0B of revenue and relatively low financial leverage. Conversely, assuming perpetual margin expansion would be aggressive if wage inflation, technology spending, competition, or contract pricing intensifies.